[Level of S-100 and neuron-specific enolase in cerebrospinal fluid from subjects with neurological pathologies].

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Revista Española de Medicina Nuclear

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 12846948
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Monitoring malignant melanoma with the S-100B tumour marker.

  2001cited by this paper
• Cerebrospinal fluid S-100beta and its relationship with AIDS dementia complex.

  2001cited by this paper
• Evaluation of Tumor Marker S-100 in Cerebrospinal Fluid from Subjects with Nonischemic Brain Pathologies

  1999cited by this paper
• Neuron-specific enolase concentrations in serum and cerebrospinal fluid in patients with no previous history of neurological disorder.

  1998cited by this paper
• S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

  1997cited by this paper
• S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction.

  1997cited by this paper
• Age- and sex-related changes of S-100 protein concentrations in cerebrospinal fluid and serum in patients with no previous history of neurological disorder.

  1997cited by this paper
• Cerebrospinal fluid levels of S‐100b protein and neuron‐specific enolase in chronic inflammatory demyelinating polyneuropathy

  1995cited by this paper
• Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease.

  1995cited by this paper
• Cerebrospinal neuron‐specific enolase, S‐100 and myelin basic protein in neurological disorders

  1995cited by this paper
• Prognostic value of cerebrospinal fluid neuron‐specific enolase and S‐100b protein in Guillain‐Barré syndrome

  1994cited by this paper
• Bacterial meningitis in children

  1992cited by this paper
• S-100ao protein in blood and urine during open-heart surgery.

  1989cited by this paper
• S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system.

  1987cited by this paper
• S100a0 (alpha alpha) protein is present in neurons of the central and peripheral nervous system.

  1984cited by this paper
• Neuron-specific enolase and S-100 protein levels in cerebrospinal fluid of patients with various neurological diseases.

  1983cited by this paper
• Assessment of damage to the central nervous system by determination of S-100 protein in the cerebrospinal fluid.

  1982cited by this paper
• Neuron-specific enolase is produced by neuroendocrine tumours.

  1981cited by this paper
• Immunoreactive nervous system of specific enolase (14-3-2 protein) in human serum and cerebrospinal fluid.

  1980cited by this paper
• MEASUREMENT OF NEURON‐SPECIFIC (NSE) AND NON‐NEURONAL (NNE) ISOENZYMES OF ENOLASE IN RAT, MONKEY AND HUMAN NERVOUS TISSUE

  1979cited by this paper
• Chronic inflammatory polyradiculoneuropathy.

  1975cited by this paper

• PROGNOSTIC VALUE OF NEURON SPECIFIC ENOLASE IN SERUM FOR OUTCOME OF INFANTS WITH BIRTH ASPHYXIA

  2016cites this paper
• Effect of Tempol on Cerebral Resuscitation Caused by Asphyxia-Induced Cardiac Arrest.

  2015cites this paper
• Clinical Utility of S-100 B Protein and Urokinase Plasminogen Activator Receptor in Children with Meningitis and Encephalitis

  2008cites this paper
• Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease?

  2008cites this paper
• Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases

  2008cites this paper
• УЧАСТИЕ НЕЙРОТРОФИЧЕСКОГО БЕЛКА S100 И ОСНОВНОГО БЕЛКА

  year unknowncites this paper